Hawaiian Ethos Medical Cannabis Is Sun-Grown and Sustainable

Hawaiian Ethos Medical Cannabis Is Sun-Grown and Sustainable Kailua-Kona—One of just two licensed medical cannabis growers and distributors on the Big Island of Hawai‘i , Hawaiian Ethos utilizes sustainable growing practices which are better for patients, the planet, and the medicine.  Sungrown on Hawai‘i Island “In Hawaiʻi, natural light is an abundant resource, so we designed our … Continue reading Hawaiian Ethos Medical Cannabis Is Sun-Grown and Sustainable

How Boxers Can Maintain a Safe and Productive Training Routine

How Boxers Can Maintain a Safe and Productive Training Routine Even though boxing is an incredible sport, it can be extremely hazardous if you aren’t careful. Coming up with a strict training routine and surrounding yourself with boxing experts will greatly reduce your risk of developing long-term health complications. Start with the Right People Many … Continue reading How Boxers Can Maintain a Safe and Productive Training Routine

Hawaiian Ethos Medical Cannabis Is Sun-Grown and Sustainable

Hawaiian Ethos Medical Cannabis Is Sun-Grown and Sustainable Kailua-Kona—One of just two licensed medical cannabis growers and distributors on the Big Island of Hawai‘i, Hawaiian Ethos’ vision is to create an example for the world that shows sustainable growing practices are better for patients, the earth, and the medicine.  Sungrown on Hawai‘i Island “In Hawaiʻi, natural light … Continue reading Hawaiian Ethos Medical Cannabis Is Sun-Grown and Sustainable

ProMIS Neurosciences Announces Second Quarter 2019 Results

ProMIS Neurosciences Announces Second Quarter 2019 Results Company continues to expand its portfolio of highly selective antibodies targeting root cause of Alzheimer’s, ALS and Parkinson’s disease  TORONTO and CAMBRIDGE, MA, Aug. 13, 2019 /CNW/ – ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting … Continue reading ProMIS Neurosciences Announces Second Quarter 2019 Results

Health Canada approves Tecentriq® (atezolizumab), first new treatment in 20 years for aggressive form of lung cancer(1)

Health Canada approves Tecentriq® (atezolizumab), first new treatment in 20 years for aggressive form of lung cancer(1) Data show Tecentriq in combination with carboplatin and etoposide helped patients with extensive-stage small cell lung cancer live longer, with a 30% reduction in the risk of death2 MISSISSAUGA, ON, Aug. 13, 2019 /CNW/ – Hoffmann-La Roche Limited … Continue reading Health Canada approves Tecentriq® (atezolizumab), first new treatment in 20 years for aggressive form of lung cancer(1)